Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money
Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.
Select the one that best describes you
Etfdb logo
MEDIA
  • ETF
  • BBH
    Pricing Data
    $113.18
    Change: $1.9 (-0.02%)
    Time: 12/18/18
    Previous Close: $115.08
  • Category
  • Health & Biotech Equities
  • ESG Score
Last Updated:

Profile

Vitals

Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $111.36
  • 52 Week Hi: $136.84
  • AUM: $390.5 M
  • Shares: 3.4 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 16,143
  • 3 Month Avg. Volume: 15,059

Alternative ETFs in the Health & Biotech Equities Category

Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $1,577.2 M 374,919 5.29%
Largest (AUM) XLV 0.13% $18,602.0 M 12,466,083 5.70%
Most Liquid (Volume) XLV 0.13% $18,602.0 M 12,466,083 5.70%
Top YTD Performer IHI 0.43% $2,915.3 M 214,889 14.77%

Analyst Report

This ETF offers targeted exposure to the biotech industry, a corner of the health care sector that is capable of delivering big returns but also exhibiting significant volatility. Given that risk/return profile, accessing biotech through the exchange-traded wrapper has some obvious appeal; it allows investors to spread out exposure, thereby increasing the opportunity of holding a stock that hits it big. Given that targeted objective, this ETF is probably most useful for those seeking tactical exposure to this corner of the market; the underlying holdings are generally found in broad-based equity ETFs, so there should be little appeal to buy-and-holders. BBH used to be structured as a HOLRDS offered by Merrill Lynch, and converted to a true ETF in 2011. It should be noted, however, that this fund still maintains some of the concentration that was characteristic of HOLDS; a few stocks receive significant allocations in the portfolio, and the top ten holdings combine to make up the majority of assets. There are some other biotech ETFs out there that may be interesting opportunities, including IBB, XBI, FBT, and PBE. Those looking for a deep, balanced portfolio will probably prefer to avoid this Market Vectors ETF and utilize a fund such as IBB or XBI instead.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for BBH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

BBH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A- n/a
Expenses A n/a
Performance
Volatility
Dividend
Concentration

Knowledge Centers

BBH In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.

BBH Holdings

Filings Data as of: Dec 18, 2018

All 26 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

Number of Holdings
Rank: 37 of 38
26
Category Low PPH (25)
Category High VHT (362)
% Assets in Top 10
Rank: 31 of 38
56.63%
Category Low BBC (11.62%)
Category High SLIM (72.58%)
% Assets in Top 15
Rank: 3 of 38
78.26%
Category Low BBC (17.27%)
Category High SLIM (82.97%)
% Assets in Top 50
Rank: 1 of 38
100.00%
Category Low BBC (55.14%)
Category High BBH (100.00%)

Asset Allocation

Asset Percentage
Common equity 100.0%

Sector Breakdown

Sector Percentage
Healthcare 100.0%

Market Cap Breakdown

Market Cap Percentage
Large cap 65.54%
Mid cap 34.46%

Region Breakdown

Region Percentage
North America 88.92%
Europe 11.08%

Market Tier Breakdown

Region Percentage
United States 88.92%
Developed Markets (ex-US) 11.08%

Country Breakdown

Country Percentage
United States 88.92%
Ireland 4.47%
Netherlands 3.83%
Spain 2.78%

BBH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.543%
ETF Wtd. Average
0.21%
Category Average
0.47%
Expense Ratio
Rank: 13 of 38
0.35%
Category Low FHLC (0.08%)
Category High CHNA (0.79%)

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 4 other ETFs in the Health & Biotech Equities ETFdb.com Category that are also eligible for commission free trading:

BBH ESG Themes and Scores
  • 4.68
    ESG Score
  • 22.07%
    ESG Score Global Percentile (%)
  • 47.76%
    ESG Score Peer Percentile (%)
  • ENVIRONMENTALLY RESPONSIBLE
    Environmental Scores
    • Revenue Exposure to Environmental Impact (%)

      Higher Improves ESG Score
    • Severe Environment Controversies (%)

      Higher Improves ESG Score
    • Sustainable Impact Solutions (%)
      38.96%

      Higher Improves ESG Score
    Carbon Intensity
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      18.72

      Lower Improves ESG Score
    Fossil Fuel Reserves
    • Fossil Fuel Reserves (%)

      Lower Improves ESG Score
    • High Impact Fossil Fuel Reserves (%)

      Lower Improves ESG Score
    Water Stress
    • Water Stress High Risk Business Segment (%)

      Lower Improves ESG Score
    • Water Stress High Risk Geography (%)

      Lower Improves ESG Score
    • Water Stress Exposure Moderate (%)

      Lower Improves ESG Score
    • Water Stress Exposure High (%)

      Lower Improves ESG Score
    • Water Stress Exposure Low (%)

      Lower Improves ESG Score
    Energy Efficiency
    • Revenue Exposure to Energy Efficiency (%)

      Higher Improves ESG Score
    Alternative Energy
    • Revenue Exposure to Alternative Energy (%)

      Higher Improves ESG Score
    Green Building
    • Revenue Exposure to Green Building (%)

      Higher Improves ESG Score
    Pollution Prevention
    • Revenue Exposure to Pollution Prevention (%)

      Higher Improves ESG Score
    Water Sustainability
    • Revenue Exposure to Water Sustainability (%)

      Higher Improves ESG Score
  • SOCIALLY RESPONSIBLE
    Social Scores
    • Revenue Exposure to Social Impact (%)

      Higher Improves ESG Score
    • Sustainable Impact Solutions (%)
      38.96%

      Higher Improves ESG Score
    • SRI Exclusion Criteria (%)
      0.0%

      Higher Improves ESG Score
    Affordable Real Estate
    • Revenue Exposure to Affordable Real Estate (%)

      Higher Improves ESG Score
    Education
    • Revenue Exposure to Education (%)

      Higher Improves ESG Score
    Major Disease Treatment
    • Revenue Exposure to Major Disease Treatment (%)

      Higher Improves ESG Score
    Healthy Nutrition
    • Revenue Exposure to Nutrition (%)

      Higher Improves ESG Score
    Global Sanitation
    • Revenue Exposure to Sanitation (%)

      Higher Improves ESG Score
    SME Finance
    • Revenue Exposure to SME Finance (%)

      Higher Improves ESG Score
    Human Rights Violations
    • Human Rights Norms Violation (%)

      Lower Improves ESG Score
    • Human Rights Norms Violation OR Watch List (%)

      Lower Improves ESG Score
    • Severe Human Rights Controversies (%)

      Lower Improves ESG Score
    Labor Rights Violations
    • Labor Norms Violation (%)

      Lower Improves ESG Score
    • Labor Norms Violation OR Watch List (%)

      Lower Improves ESG Score
    • Severe Labor Controversies (%)

      Lower Improves ESG Score
    Customer Controversies
    • Severe Customer Controversies (%)

      Lower Improves ESG Score
    UN Principles Violations
    • Global Compact Compliance Violation (%)

      Lower Improves ESG Score
    • Global Compact Compliance Violation OR Watch List (%)

      Lower Improves ESG Score
    Catholic Values
    • Catholic Values Fail (%)

      Lower Improves ESG Score
    Sharia Compliant Investing
    • Islamic Non-Compliant (%)

      Lower Improves ESG Score
    Adult Entertainment
    • Adult Entertainment Involvement (%)

      Lower Improves ESG Score
    Alcohol
    • Alcohol Involvement (%)

      Lower Improves ESG Score
    Gambling
    • Gambling Involvement (%)

      Lower Improves ESG Score
    Nuclear Power
    • Nuclear Power Involvement (%)

      Lower Improves ESG Score
    Tobacco
    • Tobacco Involvement (%)

      Lower Improves ESG Score
    Weapons Involvement
    • Weapons Involvement (%)

      Lower Improves ESG Score
    • Controversies Weapons Involvement (%)

      Lower Improves ESG Score
    Firearms
    • Civilian Firearms Involvement (%)

      Lower Improves ESG Score
    • Civilian Firearms Retailer (%)

      Lower Improves ESG Score
    • Civilian Firearms Producer (%)

      Lower Improves ESG Score
    Predatory Lending
    • Direct Predatory Lending Involvement (%)

      Lower Improves ESG Score
    GMO Involvement
    • Genetic Engineering Involvement (%)

      Lower Improves ESG Score
  • RESPONSIBLE GOVERNANCE
    Responsible Governance Score
    • Severe Governance Controversies (%)

      Lower Improves ESG Score
    Board Flag
    • Board Flag (%)

      Lower Improves ESG Score
    Board Independence
    • Lack of Independent Board Majority (%)

      Lower Improves ESG Score
    • Board Independence (0-25%) (%)

      Lower Improves ESG Score
    • Board Independence (25-50%) (%)

      Lower Improves ESG Score
    • Board Independence (50-75%) (%)

      Lower Improves ESG Score
    • Board Independence (75-100%) (%)

      Lower Improves ESG Score
    Board Diversity
    • No Female Directors (%)

      Lower Improves ESG Score
    • Three OR More Female Directors (%)

      Lower Improves ESG Score
    • Females Represent 30% of Directors (%)

      Lower Improves ESG Score
    Entrenched Board
    • Entrenched Board (%)

      Lower Improves ESG Score
    Overboarding
    • Overboarding (%)

      Lower Improves ESG Score
    Shareholder Rights
    • Negative Director Votes (%)

      Lower Improves ESG Score
    • Ownership AND Control Flag (%)

      Lower Improves ESG Score
    • One Share One Vote (%)

      Lower Improves ESG Score
    • No Annual Director Elections (%)

      Lower Improves ESG Score
    • Does Not Use Majority Voting (%)

      Lower Improves ESG Score
    • Significant Votes Against Pay Practices (%)

      Lower Improves ESG Score
    Fund Ownership
    • Controlling Shareholder (%)

      Lower Improves ESG Score
    • Controlling Shareholder Concerns (%)

      Lower Improves ESG Score
    • Cross Shareholdings (%)

      Lower Improves ESG Score
    Poison Pill
    • Poison Pill (%)

      Lower Improves ESG Score
    Executive Compensation
    • Pay Flag (%)

      Lower Improves ESG Score
    • No Pay Performance Link (%)

      Lower Improves ESG Score
    • Lack of Internal Pay Equity (%)

      Lower Improves ESG Score
    • Executive Pay Non-Disclosure (%)

      Lower Improves ESG Score
    Accounting Flags
    • Accounting Flag (%)

      Lower Improves ESG Score

BBH Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

1 Week Return
Rank: 10 of 38
-4.77%
Category Low BBC (-10.02%)
Category High KMED (-1.79%)
4 Week Return
Rank: 5 of 37
-2.87%
Category Low XPH (-9.33%)
Category High SLIM (0.03%)
13 Week Return
Rank: 18 of 37
-13.74%
Category Low BBC (-30.03%)
Category High XLV (-7.43%)
26 Week Return
Rank: 13 of 35
-6.92%
Category Low BBC (-31.81%)
Category High XLV (2.24%)
Year to Date Return
Rank: 26 of 33
-9.17%
Category Low CNCR (-19.76%)
Category High IHI (14.77%)
1 Year Return
Rank: 29 of 33
-10.00%
Category Low CNCR (-20.37%)
Category High IHI (13.43%)
3 Year Return
Rank: 22 of 28
-8.11%
Category Low CNCR (-31.22%)
Category High IHI (64.95%)
5 Year Return
Rank: 18 of 22
36.96%
Category Low XPH (-1.62%)
Category High IHI (130.04%)

BBH Fund Flows

This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.

1 Week Fund Flow
Rank: N/A
No Ranking Available
Category Low XBI (‑$68.3 M)
Category High XLV ($420.3 M)
4 Week Fund Flow
Rank: N/A
No Ranking Available
Category Low XBI (‑$123.1 M)
Category High XLV ($1,008.6 M)
13 Week Fund Flow
Rank: 24 of 33
‑$6.4 M
Category Low XBI (‑$212.2 M)
Category High XLV ($1,304.9 M)
26 Week Fund Flow
Rank: 27 of 34
‑$5.9 M
Category Low XBI (‑$377.3 M)
Category High XLV ($2,446.4 M)
Year to Date Fund Flow
Rank: 34 of 35
‑$163.7 M
Category Low IBB (‑$1,576.7 M)
Category High IXJ ($1,614.9 M)
1 Year Fund Flow
Rank: 33 of 35
‑$170.0 M
Category Low IBB (‑$1,807.1 M)
Category High IXJ ($1,648.9 M)
3 Year Fund Flow
Rank: 32 of 36
‑$253.0 M
Category Low FXH (‑$1,010.9 M)
Category High IBB ($19,701.5 M)
5 Year Fund Flow
Rank: 32 of 36
‑$212.8 M
Category Low PJP (‑$545.1 M)
Category High IBB ($20,952.8 M)

Brought to You by Mitre Media

Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of BBH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

BBH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
Rank: 26 of 36
27.79
Category Low PTH (-51.44)
Category High PBE (74.23)

BBH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$0.54
Dividend Date
2018-12-20
Annual Dividend Rate
$0.54
Annual Dividend Yield
Rank: 18 of 28
0.46%
Category Low GNRX (0.03%)
Category High IXJ (2.00%)

BBH Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

5 Day Volatility
Rank: 20 of 38
74.57%
Category Low IHF (13.13%)
Category High RYH (127.07%)
20 Day Volatility
Rank: 24 of 37
25.29%
Category Low PPH (17.18%)
Category High BTEC (43.41%)
50 Day Volatility
Rank: 15 of 37
29.46%
Category Low IXJ (20.18%)
Category High BBC (44.56%)
200 Day Volatility
Rank: 14 of 35
23.22%
Category Low IXJ (15.26%)
Category High BBC (36.69%)
Beta
Rank: 16 of 35
1.18
Category Low IHF (0.79)
Category High CNCR (2.16)
Standard Deviation
Rank: 12 of 33
5.84%
Category Low LNGR (0.89%)
Category High IHF (14.57%)

Technicals

  • 20 Day MA: $119.45
  • 60 Day MA: $123.62
  • MACD 15 Period: -6.82
  • MACD 100 Period: -13.36
  • Williams % Range 10 Day: 92.85
  • Williams % Range 20 Day: 93.12
  • RSI 10 Day: 30
  • RSI 20 Day: 37
  • RSI 30 Day: 40
  • Ultimate Oscillator: 39

Bollinger Brands

  • Lower Bollinger (10 Day): $113.60
  • Upper Bollinger (10 Day): $123.96
  • Lower Bollinger (20 Day): $113.68
  • Upper Bollinger (20 Day): $125.45
  • Lower Bollinger (30 Day): $114.20
  • Upper Bollinger (30 Day): $126.37

Support & Resistance

  • Support Level 1: $111.61
  • Support Level 2: $110.05
  • Resistance Level 1: $115.27
  • Resistance Level 2: $117.37

Stochastic

  • Stochastic Oscillator %D (1 Day): 23.07
  • Stochastic Oscillator %D (5 Day): 21.28
  • Stochastic Oscillator %K (1 Day): 27.81
  • Stochastic Oscillator %K (5 Day): 31.60

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the fact sheet PDF

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2018 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Help & Info
Tools
More Tools
Explore ETFs
Legal

Advertise With Us

© 2018 Mitre Media